Syphilis screening is routinely offered at the first antenatal visit. Does the resource spent influence on the future health of mothers and babies? Continue reading
Women presented with post-menopausal bleeding and normal blind biopsy. Is that enough to reassure the doctor and patient involved? Continue reading
Can we justify the under-representation of pregnant women in clinical trials? Are we failing pregnant women by excluding them from drug trials? Discuss the dilemma at the next #BlueJC Continue reading
Is paternal depression a significant risk factor of preterm birth? Join this #BlueJC to find out more. Continue reading
Comparing different surgical centres have been a notoriously difficult task. What can we do to compare how surgeons perform and improve quality of care for cancer patients? Continue reading
Why is it important to identify intimate partner violence during pregnancy? Explore its impact and discuss potential strategy to minimise it at #BlueJC in March 2016. Continue reading
Being overweight or obese put women and babies at higher risks of complications during pregnancy. How can we minimise these risks? Continue reading
#BlueJC on Norwegian #Fit4Delivery #RCT: reduced gestational weight gain, unchanged birthweight & obstetric outcomes. Continue reading
Social media engagement workshop at #NTCRCOG 2015. We are looking for external #BlueJC hosts! Continue reading
We will discuss “The value of male HPV vaccination in preventing cervical cancer and genital warts in a low resource setting” by Sharma and co-workers from 25 November 2015 for 7 days.
*This paper will be made FREE-TO-VIEW on 16 November 2015.
We are now on LinkedIn too: http://linkd.in/1BVrpad (simply ask to join)!
Start date: 25 November 2015 (the discussion will open for 7 days between 25 November to 2 December 2015)
First hosted discussion session(s) starts at: GMT 7pm (UK time)
The Blue Journal Club is an international journal club on women’s health research based on Twitter (as @BlueJCHost). We start our conversation on the last Wednesday of every month and use the hashtag #BlueJC for our tweets. Simply add this hashtag (“#BlueJC”) to each tweet and we will capture it. Each #BlueJC opens for 7 days with an advertised start time. All BJOG #BlueJC papers also have complementary slide sets suitable for face-to-face journal clubs with your local colleagues. You can access the slide set of this paper here (find the title paper and click on the “discussion point” tab).
The discussion points are attached below (quoted from the published manuscript)
At a conference on cervical cancer prevention, a speaker presented data on the cost-effectiveness of HPV vaccination for girls in Thailand (BJOG. 2012;119(2):166-76). An audience asked, “Would vaccinating both boys and girls be better than vaccinating girls only?”.
Description of research
|Participants||Male and female population (≥ 9 years old) in South Vietnam|
|Intervention||HPV vaccination for both male and female|
|Comparison||HPV vaccination for female only|
|Outcomes||Economical costs, estimates of cervical cancer and genital warts incidence, mortality and quality-adjusted life years (QALYS)|
|Study design||Economic evaluation using mathematical models|
- What are the incidence of cervical cancer, uptake rate of cervical screening and coverage of HPV vaccine in your country?
- What is GAVI Alliance? How does it achieve its goals?
- What are the advantages and disadvantages of using a mathematical model to address this research question? Are there alternatives?
- What is the purpose of sensitivity analysis in economical evaluations?
- What is your interpretation of the results presented? Where may the results be generalisable?
- What are the factors influencing how policy makers utilise findings of economical evaluations?
- How can researchers maximise the potential of their research being utilised for health policy decision-making?
- Should we give HPV vaccines to all boys in LMICs?
- Critical Appraisal Skills Programme checklist for economical evaluation. http://bit.ly/1EX0KXE
- Cohen DJ, Reynolds MR. Interpreting the results of cost-effectiveness studies. J Am Coll Cardiol. 2008 Dec 16;52(25):2119-26.
- Linhares IM, Witkin SS. HPV vaccination: unanswered questions remain. BJOG. 2015 Jan;122(1):118.
- Gold M. Pathways to the use of health services research in policy. Health Serv Res. 2009 Aug;44(4):1111-36.
- Haynes AS, Gillespie JA, Derrick GE, Hall WD, Redman S, Chapman S, Sturk H. Galvanizers, guides, champions, and shields: the many ways that policymakers use public health researchers. Milbank Q. 2011 Dec;89(4):564-98.
For those who want to understand hashtags, this may be a useful guide. For an introduction to #BlueJC, please refer to BJOG 2013;120:657–60. Follow @BlueJCHost, this blog and our Facebook page to receive news about #BlueJC.